PharmiWeb.com - Global Pharma News & Resources
11-Dec-2024

Continuous Glucose Monitoring Market Set for Robust Growth, Projected to Reach US$ 2 Billion by 2028

The global continuous glucose monitoring (CGM) devices market is experiencing a notable surge, with an estimated compound annual growth rate (CAGR) of 9.5% from 2021 to 2028. The market, valued at approximately US$ 992.8 million in 2020, is expected to surpass US$ 2 billion by the end of 2028, driven by the rising prevalence of diabetes, advancements in CGM technology, and increasing consumer demand for personalized healthcare solutions.

Download now to explore primary insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1169

Market Overview

Continuous glucose monitoring systems offer real-time glucose readings, which enable diabetes patients to better manage their condition and avoid dangerous spikes or dips in blood sugar levels. CGM devices have proven to be a crucial tool for people living with Type 1 and Type 2 diabetes, offering patients an advanced way to monitor their glucose levels without the need for traditional fingerstick testing. Devices like the Guardian Real Time CGM System, Freestyle Navigator, Dexcom Seven Plus, and MiniMed Paradigm Revel/Veo Systems, among others, are gaining substantial traction for their ease of use, accuracy, and ability to integrate with smartphones and other wearable devices.

The market for CGM devices is expanding rapidly, with leading players such as Abbott, Medtronic, Dexcom, and others continuously innovating to improve sensor accuracy, device connectivity, and user experience. The demand for CGM systems is further heightened by growing consumer awareness about diabetes management and the shift towards more proactive, data-driven healthcare.

Key Drivers and Trends

Several key factors are driving the growth of the continuous glucose monitoring market:

  1. Rising Prevalence of Diabetes: The global rise in diabetes cases, both Type 1 and Type 2, is a significant driver for the CGM market. The World Health Organization (WHO) estimates that over 400 million people worldwide are living with diabetes, a number that is expected to increase. This growing patient base creates substantial demand for effective management solutions like CGM devices.
  2. Technological Advancements: Continuous advancements in CGM technology, including improved sensors, longer wear times, and better connectivity with smartphones and wearable devices, are making these products more user-friendly and effective. Innovations in the development of non-invasive glucose monitoring methods are also opening up new avenues for market growth.
  3. Increasing Awareness and Demand for Personalized Health Management: Patients are increasingly opting for personalized healthcare solutions that provide real-time data and detailed insights into their health, driving the growth of CGM systems.
  4. Integration with Digital Health Platforms: The integration of CGM devices with telemedicine services, cloud-based analytics platforms, and mobile applications enables more effective monitoring and management of diabetes. This connectivity trend is fostering more patient engagement and improving healthcare outcomes.

Buy this Premium Research Report for a deep dive into essential data - https://www.transparencymarketresearch.com/continuous-glucose-monitoring.html 

Market Opportunities

The continuous glucose monitoring market offers substantial opportunities, particularly in emerging economies where diabetes incidence is on the rise. Companies can tap into new markets by offering affordable, high-quality devices and exploring partnerships with local healthcare providers to expand access to CGM systems. Additionally, the increasing adoption of remote patient monitoring and telehealth services presents new opportunities for CGM manufacturers to enhance their product offerings.

Regional Analysis

North America dominates the global CGM market, with the United States being a major contributor due to high healthcare expenditure, advanced medical infrastructure, and high diabetes prevalence. The market in Europe is also experiencing steady growth, fueled by an aging population and increasing government healthcare spending. In contrast, the Asia Pacific region is expected to witness the fastest growth during the forecast period due to rising healthcare awareness, the increasing incidence of diabetes, and improved healthcare accessibility in countries like China and India.

Market Segmentation

The continuous glucose monitoring market is segmented based on device type, end-user, and region:

  • Device Type: Key products include sensor-based CGM devices, which account for the largest market share, and implantable CGM devices.
  • End-User: Hospitals, clinics, and home care settings are the primary end-users of CGM systems.
  • Region: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Leading Companies

Key players in the global continuous glucose monitoring market include:

  • Abbott
  • Bayer AG
  • Dexcom, Inc.
  • Glysens Incorporated
  • Insulet Corporation
  • Medtronic
  • Nova Biomedical Corporation
  • Senseonics Incorporated
  • Livongo
  • BeatO
  • Jana Care
  • iXensor
  • DiaMonTech AG.

These companies are investing heavily in R&D, strategic collaborations, and acquisitions to strengthen their positions in the competitive market.

Download now to explore primary insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1169

Explore Latest Research Reports by Transparency Market Research:

Single-Use Bioreactors Market: Estimated to advance at a CAGR of 10.8% from 2024 to 2034 and reach 6.7 Bn by the end of 2034

Endoscopic Vessel Harvesting Systems Market: It is estimated to grow at a CAGR of 3.5% from 2023 to 2031 and reach US$ 686.6 Mn by the end of 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

Continuous Glucose Monitoring Market Set for Robust Growth, Projected to Reach US$ 2 Billion by 2028

Editor Details

Related Links

Last Updated: 12-Dec-2024